Testing-Rising xxxx

The seventh annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.

XXXXtesting

Other top 20 players also moved up in the rankings fired by double-digit growth. Lilly, Novo Nordisk and Amgen all gained on the Scrip 100, which is based on FY 2024 pharmaceutical sales.

Top 30 leaders: see the list of industry influencers highlighted in the sixth edition of In Vivo's Rising Leaders series.